Goater Jeff
Insider CIK 1656435 · VCNX Director · VYGR Chief Financial Officer · LOGC Director · SURF Chief Executive Officer, Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| SURF Surface Oncology, Inc. | D To issuer | 2023-09-08 | 2023-09-08 | 129,222 | — | $0 | 0 | SEC↗ |
| LOGC LogicBio Therapeutics, Inc | D To issuer deriv | 2022-11-16 | 2022-11-17 | 12,500 | — | $0 | 0 | SEC↗ |
| LOGC LogicBio Therapeutics, Inc | A Award deriv | 2022-06-17 | 2022-06-21 | 12,500 | — | $0 | 12,500 | SEC↗ |
| SURF Surface Oncology, Inc. | A Award deriv | 2022-06-08 | 2022-06-10 | 24,000 | — | $0 | 24,000 | SEC↗ |
| SURF Surface Oncology, Inc. | S Sale | 2021-07-21 | 2022-01-14 | 127,778 | $6.10 | $779.4K | 129,222 | SEC↗ |
| SURF Surface Oncology, Inc. | M Exercise deriv | 2021-06-11 | 2021-06-11 | 10,273 | — | $0 | 93,831 | SEC↗ |
| LOGC LogicBio Therapeutics, Inc | A Award deriv | 2021-06-11 | 2021-06-14 | 12,500 | — | $0 | 12,500 | SEC↗ |
| SURF Surface Oncology, Inc. | M Exercise | 2021-06-11 | 2021-06-11 | 10,273 | $4.14 | $42.5K | 272,273 | SEC↗ |
| SURF Surface Oncology, Inc. | S Sale | 2021-06-11 | 2021-06-11 | 15,273 | $7.61 | $116.2K | 257,000 | SEC↗ |
| SURF Surface Oncology, Inc. | M Exercise deriv | 2021-06-10 | 2021-06-11 | 200,000 | — | $0 | 104,104 | SEC↗ |
| SURF Surface Oncology, Inc. | M Exercise deriv | 2021-06-10 | 2021-06-11 | 34,727 | — | $0 | 10,325 | SEC↗ |
| SURF Surface Oncology, Inc. | M Exercise | 2021-06-10 | 2021-06-11 | 34,727 | $4.14 | $143.8K | 496,727 | SEC↗ |
| SURF Surface Oncology, Inc. | M Exercise | 2021-06-10 | 2021-06-11 | 200,000 | $4.14 | $828.0K | 462,000 | SEC↗ |
| SURF Surface Oncology, Inc. | S Sale | 2021-06-10 | 2021-06-11 | 234,727 | $7.66 | $1.80M | 262,000 | SEC↗ |
| VCNX VACCINEX, INC. | A Award deriv | 2021-05-11 | 2021-05-12 | 28,586 | — | $0 | 28,586 | SEC↗ |
| SURF Surface Oncology, Inc. | A Award deriv | 2021-04-01 | 2021-04-02 | 15,000 | — | $0 | 15,000 | SEC↗ |
| SURF Surface Oncology, Inc. | A Award deriv | 2021-04-01 | 2021-04-02 | 15,000 | — | $0 | 15,000 | SEC↗ |
| SURF Surface Oncology, Inc. | A Award deriv | 2021-04-01 | 2021-04-02 | 35,400 | — | $0 | 35,400 | SEC↗ |
| SURF Surface Oncology, Inc. | A Award deriv | 2021-04-01 | 2021-04-02 | 4,425 | — | $0 | 4,425 | SEC↗ |
| SURF Surface Oncology, Inc. | M Exercise deriv | 2021-02-08 | 2021-02-09 | 2,500 | — | $0 | 247,000 | SEC↗ |
| SURF Surface Oncology, Inc. | S Sale | 2021-02-08 | 2021-02-09 | 2,500 | $12.50 | $31.3K | 262,000 | SEC↗ |
| SURF Surface Oncology, Inc. | M Exercise | 2021-02-08 | 2021-02-09 | 2,500 | $3.18 | $8.0K | 264,500 | SEC↗ |
| SURF Surface Oncology, Inc. | M Exercise deriv | 2021-02-01 | 2021-02-03 | 2,500 | — | $0 | 249,500 | SEC↗ |
| SURF Surface Oncology, Inc. | S Sale | 2021-02-01 | 2021-02-03 | 2,500 | $10.69 | $26.7K | 262,000 | SEC↗ |
| SURF Surface Oncology, Inc. | M Exercise | 2021-02-01 | 2021-02-03 | 2,500 | $3.18 | $8.0K | 264,500 | SEC↗ |
| SURF Surface Oncology, Inc. | M Exercise deriv | 2021-01-19 | 2021-01-21 | 5,000 | — | $0 | 252,000 | SEC↗ |
| SURF Surface Oncology, Inc. | S Sale | 2021-01-19 | 2021-01-21 | 5,000 | $13.00 | $65.0K | 262,000 | SEC↗ |
| SURF Surface Oncology, Inc. | M Exercise | 2021-01-19 | 2021-01-21 | 5,000 | $3.18 | $15.9K | 267,000 | SEC↗ |
| LOGC LogicBio Therapeutics, Inc | A Award deriv | 2020-12-10 | 2020-12-14 | 20,000 | — | $0 | 20,000 | SEC↗ |
| VCNX VACCINEX, INC. | A Award deriv | 2020-05-14 | 2020-05-18 | 15,679 | — | $0 | 15,679 | SEC↗ |
| SURF Surface Oncology, Inc. | P Buy | 2020-02-05 | 2020-02-07 | 5,000 | $3.23 | $16.1K | 262,000 | SEC↗ |
| SURF Surface Oncology, Inc. | A Award deriv | 2020-02-03 | 2020-02-05 | 257,000 | — | $0 | 257,000 | SEC↗ |
| SURF Surface Oncology, Inc. | A Award | 2020-02-03 | 2020-02-05 | 257,000 | — | $0 | 257,000 | SEC↗ |
| VCNX VACCINEX, INC. | A Award deriv | 2019-05-15 | 2019-05-17 | 7,718 | — | $0 | 7,718 | SEC↗ |
| SURF Surface Oncology, Inc. | A Award deriv | 2019-03-01 | 2019-03-04 | 300,000 | — | $0 | 300,000 | SEC↗ |
| VYGR Voyager Therapeutics, Inc. | A Award deriv | 2016-02-01 | 2016-02-02 | 25,000 | $11.09 | $277.3K | 65,000 | SEC↗ |
| VYGR Voyager Therapeutics, Inc. | A Award deriv | 2016-02-01 | 2016-02-02 | 40,000 | $11.09 | $443.6K | 40,000 | SEC↗ |